What question did this study set out to answer?

Assess progress towards measles and rubella elimination in the WHO Eastern Mediterranean Region during 2023–2024.

July 29, 2026VaccinesOpen Access

Measles and Rubella Elimination Trends in the WHO Eastern Mediterranean Region, 2023–2024: Progress and Recent Epidemiological Shifts

View Full Paper

Ask AI

Bookmark

Assess progress towards measles and rubella elimination in the WHO Eastern Mediterranean Region during 2023–2024.
Conducted a retrospective descriptive analysis of surveillance data for all 22 EMR countries and territories.
Analyzed WHO/UNICEF Estimates of National Immunization Coverage data and Joint Reporting Form data.
Key indicators included disease incidence and MCV1 and MCV2 coverage.
Measles incidence increased from 110.8 to 116.3 per million population, while rubella incidence increased from 1.9 to 4.3 per million.
MCV1 coverage remained stable at 80%; MCV2 coverage increased from 73% to 75%; only nine countries achieved ≥95% coverage for both doses.
Ongoing immunity gaps and sizable zero-dose populations contributed to sustained disease transmission.

No takes yet. Share an insight, caveat, or question.

Retrospective analysis assesses measles and rubella elimination progress in the EMR, indicating urgent need for action.

Farid et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark